Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Pathology|November 9, 2020
Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten lossDébora C Bastos, Caroline F Ribeiro, Thomas Ahearn, et al.
Cancers|September 23, 2022
Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision MedicineEdoardo Francini, Giuseppe Nicolò Fanelli, Filippo Pederzoli, et al.
Critical Reviews in Oncology/Hematology|August 22, 2025
Targeting cancer metabolism: Therapeutic potential of the fatty acid synthase (FASN) inhibitorsPier Vitale Nuzzo, Silvia Rodrigues, Caroline Fidalgo Ribeiro, et al.
Science Translational Medicine|May 3, 2023
Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancerMengdie Wang, Christi A Wisniewski, Choua Xiong, et al.
Nature Communications|June 8, 2021
Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancerNicholas J Brady, Alyssa M Bagadion, Richa Singh, et al.
Prostate Cancer and Prostatic Diseases|March 13, 2026
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapySara Bleve, Francesco Ravera, Silvia Rodrigues, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progressionSilvia D Rodrigues, Caroline Fidalgo Ribeiro, Giuseppe N Fanelli, et al.
Molecular Cell|August 7, 2018
Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate OncogenesisGabriel J Sandoval, John L Pulice, Hubert Pakula, et al.
Pageof 3